Literature DB >> 32459357

Nonthyroidal Illness Syndrome and Hypothyroidism in Ischemic Heart Disease Population: A Systematic Review and Meta-Analysis.

Chun-Yu Chang1, Yung-Jiun Chien2, Po-Chen Lin3,4, Chien-Sheng Chen3,4, Meng-Yu Wu3,4.   

Abstract

CONTEXT: The association of non-thyroidal illness syndrome (NTIS) and hypothyroidism with the prognosis in ischemic heart disease (IHD) population is inconclusive.
OBJECTIVE: We aimed to evaluate the influence of NTIS and hypothyroidism on all-cause mortality and major adverse cardiac events (MACE) in IHD population. DATA SOURCES: We searched PubMed, EMBASE, Scopus, Web of Science, and Cochrane Library from inception through February 17, 2020. STUDY SELECTION: Original articles enrolling IHD patients, comparing all-cause mortality and MACE of NTIS and hypothyroidism with those of euthyroidism, and providing sufficient information for meta-analysis were considered eligible. DATA EXTRACTION: Relevant information and numerical data were extracted for methodological assessment and meta-analysis. DATA SYNTHESIS: Twenty-three studies were included. The IHD population with NTIS was associated with higher risk of all-cause mortality (hazard ratio [HR] = 2.61; 95% confidence interval [CI] = 1.89-3.59) and MACE (HR = 2.22; 95% CI = 1.71-2.89) than that without. In addition, the IHD population with hypothyroidism was also associated with higher risk of all-cause mortality (HR = 1.47; 95% CI = 1.10-1.97) and MACE (HR = 1.53; 95% CI = 1.19-1.97) than that without. In the subgroup analysis, the acute coronary syndrome (ACS) subpopulation with NTIS was associated with higher risk of all-cause mortality (HR = 3.30; 95% CI = 2.43-4.48) and MACE (HR = 2.19; 95% CI = 1.45-3.30). The ACS subpopulation with hypothyroidism was also associated with higher risk of all-cause mortality (HR = 1.67; 95% CI = 1.17-2.39).
CONCLUSIONS: The IHD population with concomitant NTIS or hypothyroidism was associated with higher risk of all-cause mortality and MACE. Future research is required to provide evidence of the causal relationship and to elucidate whether normalizing thyroid function parameters can improve prognosis. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  hypothyroidism; major adverse cardiac events; meta-analysis; mortality; non-thyroidal illness syndrome

Mesh:

Year:  2020        PMID: 32459357     DOI: 10.1210/clinem/dgaa310

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  The prognostic impact of thyroid disorders on the clinical severity of COVID-19: Results of single-centre pandemic hospital.

Authors:  Mehmet Güven; Hamza Gültekin
Journal:  Int J Clin Pract       Date:  2021-03-13       Impact factor: 3.149

2.  Thyroid Dysfunction in Patients Admitted in Cardiac Care Unit: Prevalence, Characteristic and Hospitalization Outcomes.

Authors:  Abdulrahman AlQahtani; Ziyad Alakkas; Fayez Althobaiti; Mohammed Alosaimi; Baraa Abuzinadah; Elshazly Abdulkhalik; Khaled Alswat
Journal:  Int J Gen Med       Date:  2021-02-18

Review 3.  Minor perturbations of thyroid homeostasis and major cardiovascular endpoints-Physiological mechanisms and clinical evidence.

Authors:  Patrick Müller; Melvin Khee-Shing Leow; Johannes W Dietrich
Journal:  Front Cardiovasc Med       Date:  2022-08-15

4.  Nonthyroidal illness syndrome in acute pancreatitis patients: an 8-year cohort study.

Authors:  Cheng Qu; Zehua Duan; Xiaojia Xiao; Mei Wei; Kun Gao; Xianqiang Yu; Lu Ke; Zhihui Tong; Weiqin Li
Journal:  BMC Gastroenterol       Date:  2022-02-03       Impact factor: 3.067

Review 5.  Thyroid and heart, a clinically relevant relationship.

Authors:  G Corona; L Croce; C Sparano; L Petrone; A Sforza; M Maggi; L Chiovato; M Rotondi
Journal:  J Endocrinol Invest       Date:  2021-05-25       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.